Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Morinda citrifolia, commonly known as noni or Indian mulberry, is an evergreen tree native to the Pacific Islands, Southeast Asia, Australia, and India. Traditionally used in herbal medicine for a variety of ailments including colds, bacterial infections, fevers, gastrointestinal problems[2][3][4], and more recently promoted as a dietary supplement for immune system health and digestive health[2]. The fruit contains compounds such as anthraquinones (e.g., damnacanthal), lignans[3], essential oils (hexanoic and octanoic acids), and other phytochemicals. Laboratory studies suggest antioxidant[3], immunomodulating[3], antimicrobial[5], antifungal[5], antiviral (notably against Epstein-Barr virus)[3], anti-inflammatory[5], analgesic[5] and antitumor properties; however clinical evidence in humans is limited or lacking for most indications. Noni juice has been studied for potential benefits in reducing LDL oxidation (cardiovascular protection)[3] and postoperative nausea/vomiting reduction in one study[3]. The mechanism of action is not fully established but may involve modulation of immune responses (macrophage activation/nitric oxide production) and antioxidant effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on morinda citrifolia.